Dramatical Response to "Low Dose Ultra-Slow Infusion" of Alteplase for Massive Mitral Mechanical Valve Thrombosis

Anatol J Cardiol. 2022 May;26(5):E6-E7. doi: 10.5152/AnatolJCardiol.2022.1596.
No abstract available

MeSH terms

  • Fibrinolytic Agents / therapeutic use
  • Heart Valve Prosthesis* / adverse effects
  • Humans
  • Mitral Valve
  • Thrombolytic Therapy
  • Thrombosis* / diagnostic imaging
  • Thrombosis* / drug therapy
  • Tissue Plasminogen Activator / therapeutic use

Substances

  • Fibrinolytic Agents
  • Tissue Plasminogen Activator